# Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP

> **NCT07552324** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 28 (estimated)

## Conditions studied

- DHL
- THL
- DLBCL - Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** CL-Pola-R-CHP

## Key facts

- **NCT ID:** NCT07552324
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2028-05-30
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552324, "Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07552324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*